vs

Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and SunCoke Energy, Inc. (SXC). Click either name above to swap in a different company.

SunCoke Energy, Inc. is the larger business by last-quarter revenue ($480.2M vs $270.8M, roughly 1.8× HUTCHMED (China) Ltd). HUTCHMED (China) Ltd runs the higher net margin — 0.7% vs -17.8%, a 18.5% gap on every dollar of revenue. On growth, SunCoke Energy, Inc. posted the faster year-over-year revenue change (-1.2% vs -16.5%). SunCoke Energy, Inc. produced more free cash flow last quarter ($32.8M vs $3.4M).

HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.

Energy Brands, also doing business as Glacéau, is a privately owned subsidiary of the Coca-Cola Company based in Whitestone, Queens, New York, that manufactures and distributes various lines of drinks marketed as enhanced water. Founded in May 1996 by J. Darius Bikoff with an electrolyte enhanced line of water called Smartwater, Energy Brands initially distributed its products to health food stores and independent retailers in the New York area. Adding Fruitwater and Vitaminwater to its line ...

HCM vs SXC — Head-to-Head

Bigger by revenue
SXC
SXC
1.8× larger
SXC
$480.2M
$270.8M
HCM
Growing faster (revenue YoY)
SXC
SXC
+15.3% gap
SXC
-1.2%
-16.5%
HCM
Higher net margin
HCM
HCM
18.5% more per $
HCM
0.7%
-17.8%
SXC
More free cash flow
SXC
SXC
$29.4M more FCF
SXC
$32.8M
$3.4M
HCM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HCM
HCM
SXC
SXC
Revenue
$270.8M
$480.2M
Net Profit
$2.0M
$-85.6M
Gross Margin
37.7%
Operating Margin
-13.2%
-20.4%
Net Margin
0.7%
-17.8%
Revenue YoY
-16.5%
-1.2%
Net Profit YoY
-83.6%
-461.2%
EPS (diluted)
$0.00
$-1.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HCM
HCM
SXC
SXC
Q4 25
$270.8M
$480.2M
Q3 25
$487.0M
Q2 25
$277.7M
$434.1M
Q1 25
$324.5M
$436.0M
Q4 24
$486.0M
Q3 24
$490.1M
Q2 24
$305.7M
$470.9M
Q1 24
$488.4M
Net Profit
HCM
HCM
SXC
SXC
Q4 25
$2.0M
$-85.6M
Q3 25
$22.2M
Q2 25
$455.0M
$1.9M
Q1 25
$11.9M
$17.3M
Q4 24
$23.7M
Q3 24
$30.7M
Q2 24
$25.8M
$21.5M
Q1 24
$20.0M
Gross Margin
HCM
HCM
SXC
SXC
Q4 25
37.7%
Q3 25
Q2 25
0.1%
Q1 25
48.0%
Q4 24
Q3 24
Q2 24
41.1%
Q1 24
Operating Margin
HCM
HCM
SXC
SXC
Q4 25
-13.2%
-20.4%
Q3 25
2.8%
Q2 25
-1.3%
2.3%
Q1 25
-5.0%
6.9%
Q4 24
7.3%
Q3 24
9.6%
Q2 24
-9.0%
7.4%
Q1 24
7.1%
Net Margin
HCM
HCM
SXC
SXC
Q4 25
0.7%
-17.8%
Q3 25
4.6%
Q2 25
163.8%
0.4%
Q1 25
3.7%
4.0%
Q4 24
4.9%
Q3 24
6.3%
Q2 24
8.4%
4.6%
Q1 24
4.1%
EPS (diluted)
HCM
HCM
SXC
SXC
Q4 25
$0.00
$-1.00
Q3 25
$0.26
Q2 25
$0.52
$0.02
Q1 25
$0.01
$0.20
Q4 24
$0.28
Q3 24
$0.36
Q2 24
$0.03
$0.25
Q1 24
$0.23

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HCM
HCM
SXC
SXC
Cash + ST InvestmentsLiquidity on hand
$1.4B
$88.7M
Total DebtLower is stronger
$93.2M
$685.5M
Stockholders' EquityBook value
$1.2B
$597.3M
Total Assets
$1.8B
$1.8B
Debt / EquityLower = less leverage
0.08×
1.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HCM
HCM
SXC
SXC
Q4 25
$1.4B
$88.7M
Q3 25
$80.4M
Q2 25
$1.4B
$186.2M
Q1 25
$836.1M
$193.7M
Q4 24
$189.6M
Q3 24
$164.7M
Q2 24
$802.5M
$81.9M
Q1 24
$120.1M
Total Debt
HCM
HCM
SXC
SXC
Q4 25
$93.2M
$685.5M
Q3 25
$691.1M
Q2 25
$93.4M
$493.4M
Q1 25
$82.8M
$492.9M
Q4 24
$492.3M
Q3 24
$491.8M
Q2 24
$82.1M
$491.3M
Q1 24
$490.8M
Stockholders' Equity
HCM
HCM
SXC
SXC
Q4 25
$1.2B
$597.3M
Q3 25
$695.9M
Q2 25
$1.2B
$677.7M
Q1 25
$759.9M
$684.6M
Q4 24
$680.2M
Q3 24
$658.6M
Q2 24
$740.1M
$636.9M
Q1 24
$623.0M
Total Assets
HCM
HCM
SXC
SXC
Q4 25
$1.8B
$1.8B
Q3 25
$1.9B
Q2 25
$1.8B
$1.6B
Q1 25
$1.3B
$1.7B
Q4 24
$1.7B
Q3 24
$1.7B
Q2 24
$1.3B
$1.7B
Q1 24
$1.7B
Debt / Equity
HCM
HCM
SXC
SXC
Q4 25
0.08×
1.15×
Q3 25
0.99×
Q2 25
0.08×
0.73×
Q1 25
0.11×
0.72×
Q4 24
0.72×
Q3 24
0.75×
Q2 24
0.11×
0.77×
Q1 24
0.79×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HCM
HCM
SXC
SXC
Operating Cash FlowLast quarter
$8.2M
$56.6M
Free Cash FlowOCF − Capex
$3.4M
$32.8M
FCF MarginFCF / Revenue
1.2%
6.8%
Capex IntensityCapex / Revenue
1.8%
5.0%
Cash ConversionOCF / Net Profit
4.21×
TTM Free Cash FlowTrailing 4 quarters
$-96.2M
$42.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HCM
HCM
SXC
SXC
Q4 25
$8.2M
$56.6M
Q3 25
$9.2M
Q2 25
$-72.9M
$17.5M
Q1 25
$40.3M
$25.8M
Q4 24
$60.9M
Q3 24
$107.2M
Q2 24
$-39.8M
$-9.3M
Q1 24
$10.0M
Free Cash Flow
HCM
HCM
SXC
SXC
Q4 25
$3.4M
$32.8M
Q3 25
$-16.3M
Q2 25
$-82.2M
$4.9M
Q1 25
$32.5M
$20.9M
Q4 24
$36.1M
Q3 24
$92.1M
Q2 24
$-49.9M
$-26.8M
Q1 24
$-5.5M
FCF Margin
HCM
HCM
SXC
SXC
Q4 25
1.2%
6.8%
Q3 25
-3.3%
Q2 25
-29.6%
1.1%
Q1 25
10.0%
4.8%
Q4 24
7.4%
Q3 24
18.8%
Q2 24
-16.3%
-5.7%
Q1 24
-1.1%
Capex Intensity
HCM
HCM
SXC
SXC
Q4 25
1.8%
5.0%
Q3 25
5.2%
Q2 25
3.3%
2.9%
Q1 25
2.4%
1.1%
Q4 24
5.1%
Q3 24
3.1%
Q2 24
3.3%
3.7%
Q1 24
3.2%
Cash Conversion
HCM
HCM
SXC
SXC
Q4 25
4.21×
Q3 25
0.41×
Q2 25
-0.16×
9.21×
Q1 25
3.38×
1.49×
Q4 24
2.57×
Q3 24
3.49×
Q2 24
-1.54×
-0.43×
Q1 24
0.50×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons